<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100962781</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22270</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-003X</issn>
<issn pub-type="epub">1471-0048</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27194476</article-id>
<article-id pub-id-type="pmc">6276815</article-id>
<article-id pub-id-type="doi">10.1038/nrn.2016.46</article-id>
<article-id pub-id-type="manuscript">NIHMS997801</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mertens</surname>
<given-names>Jerome</given-names>
</name>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Marchetto</surname>
<given-names>Maria C.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bardy</surname>
<given-names>Cedric</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gage</surname>
<given-names>Fred H.</given-names>
</name>
</contrib>
<aff id="A1">Salk Institute for Biological Studies, Laboratory of Genetics, La Jolla, California 92037, USA.</aff>
</contrib-group>
<author-notes>
<corresp id="CR1">Correspondence to F.H.G. <email>gage@salk.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P40">Competing interests statement</p>
<p id="P41">The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>17</volume>
<issue>7</issue>
<fpage>424</fpage>
<lpage>437</lpage>
<!--elocation-id from pubmed: 10.1038/nrn.2016.46-->
<abstract id="ABS1">
<p id="P1">The scarcity of live human brain cells for experimental access has for a long time limited our ability to study complex human neurological disorders and elucidate basic neuroscientific mechanisms. A decade ago, the development of methods to reprogramme somatic human cells into induced pluripotent stem cells enabled the <italic>in vitro</italic> generation of a wide range of neural cells from virtually any human individual. The growth of methods to generate more robust and defined neural cell types through reprogramming and direct conversion into induced neurons has led to the establishment of various human reprogramming-based neural disease models.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>